Skip to main content
Annals of Surgery logoLink to Annals of Surgery
. 1982 Feb;195(2):163–167. doi: 10.1097/00000658-198202000-00007

A prospective analysis of laboratory tests and imaging studies to detect hepatic lesions.

M M Kemeny, P H Sugarbaker, T J Smith, B K Edwards, T Shawker, M Vermess, A E Jones
PMCID: PMC1352436  PMID: 7055392

Abstract

A prospective study of the ability of laboratory tests and liver imaging tests to detect hepatic metastases was performed. Eighty patients at risk for hepatic metastases but without clinical evidence of disease were tested with 13 laboratory tests and three liver imaging tests. No single laboratory test had greater than 65% accuracy in the detection of hepatic lesions. No combination of the laboratory tests increased this accuracy. If the laboratory tests were used with one of the liver imaging tests, the accuracy was improved in some combinations to 76%. The CEA assay when analyzed in patients with colorectal primaries had an accuracy of 79%. The results show that the laboratory tests alone are not sufficiently accurate to detect liver metastases. Additional accuracy can be obtained by the combined use of a single liver imaging test and selected laboratory tests. Use of all the liver imaging tests and laboratory tests lowers the accuracy and increases the expense and thus is unnecessary.

Full text

PDF
166

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adson M. A., Van Heerden J. A. Major hepatic resections for metastatic colorectal cancer. Ann Surg. 1980 May;191(5):576–583. doi: 10.1097/00000658-198005000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aronsen K. F., Nosslin B., Pihl B. The value of gamma-glutamyl transpeptidase as a screen test for liver tumour. Acta Chir Scand. 1970;136(1):17–22. [PubMed] [Google Scholar]
  3. Baden H., Andersen B., Augustenborg G., Hanel H. K. Diagnostic value of gamma-glutamyl transpeptidase and alkaline phosphatase in liver metastases. Surg Gynecol Obstet. 1971 Nov;133(5):769–773. [PubMed] [Google Scholar]
  4. Castagna J., Benfield J. R., Yamada H., Johnson D. E. The reliability of liver scans and function tests in detecting metastases. Surg Gynecol Obstet. 1972 Mar;134(3):463–466. [PubMed] [Google Scholar]
  5. Cederqvist C., Nielsen J. Value of liver function tests in the diagnosis of hepatic metastases in patients with gastric cancer. Acta Chir Scand. 1972;138(6):604–608. [PubMed] [Google Scholar]
  6. Felix E. L., Bagley D. H., Sindelar W. F., Johnston G. S., Ketcham A. S. The value of the liver scan in preoperative screening of patients with malignancies. Cancer. 1976 Sep;38(3):1137–1141. doi: 10.1002/1097-0142(197609)38:3<1137::aid-cncr2820380314>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  7. Huguier M., Lacaine F. Hepatic metastases in gastrointestinal cancer: diagnostic value of biochemical investigations. Arch Surg. 1981 Apr;116(4):399–401. doi: 10.1001/archsurg.1981.01380160017004. [DOI] [PubMed] [Google Scholar]
  8. KOWLESSAR O. D., HAEFFNER L. J., RILEY E. M., SLEISENGER M. H. Comparative study of serum leucine aminopeptidase, 5-nucleotidase and non-specific alkaline phosphatase in diseases affecting the pancreas, hepatobiliary tree and bone. Am J Med. 1961 Aug;31:231–237. doi: 10.1016/0002-9343(61)90111-5. [DOI] [PubMed] [Google Scholar]
  9. McCartney W. H., Hoffer P. B. Carcinoembryonic antigen assay in hepatic metastases detection. An adjunct to liver scanning. JAMA. 1976 Aug 30;236(9):1023–1027. [PubMed] [Google Scholar]
  10. McNeil B. J., Adelstein S. J. Determining the value of diagnostic and screening tests. J Nucl Med. 1976 Jun;17(6):439–448. [PubMed] [Google Scholar]
  11. RUTENBURG A. M., BANKS B. M., PINEDA E. P., GOLDBARG J. A. A COMPARISON OF SERUM AMINOPEPTIDASE AND ALKALINE PHOSPHATASE IN THE DETECTION OF HEPATOBILIARY DISEASE IN ANICTERIC PATIENTS. Ann Intern Med. 1964 Jul;61:50–55. doi: 10.7326/0003-4819-61-1-50. [DOI] [PubMed] [Google Scholar]
  12. Ranson J. H., Adams P. X., Localio S. A. Preoperative assessment for hepatic metastases in carcinoma of the colon and rectum. Surg Gynecol Obstet. 1973 Sep;137(3):435–438. [PubMed] [Google Scholar]
  13. Rosenthal S., Kaufman S. The liver scan in metastatic disease. Arch Surg. 1973 May;106(5):656–659. doi: 10.1001/archsurg.1973.01350170028007. [DOI] [PubMed] [Google Scholar]
  14. Schaefer J., Schiff L. Liver function tests in metastatic tumor of the liver: study of 100 cases. Gastroenterology. 1965 Oct;49(4):360–363. [PubMed] [Google Scholar]
  15. Sugarbaker P. H., Beard J. O., Drum D. E. Detection of hepatic metastases from cancer of the breast. Am J Surg. 1977 Apr;133(4):531–535. doi: 10.1016/0002-9610(77)90143-x. [DOI] [PubMed] [Google Scholar]
  16. Tsou K. C., Lo K. W. Serum 5'--nucleotide phosphodiesterase isozyme--V test for human liver cancer. Cancer. 1980 Jan 15;45(2):209–213. doi: 10.1002/1097-0142(19800115)45:2<209::aid-cncr2820450202>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  17. Wanebo H. J., Rao B., Pinsky C. M., Hoffman R. G., Stearns M., Schwartz M. K., Oettgen H. F. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med. 1978 Aug 31;299(9):448–451. doi: 10.1056/NEJM197808312990904. [DOI] [PubMed] [Google Scholar]
  18. Wilson F. E., Preston D. F., Overholt E. L. Detection of hepatic neoplasm. Hepatic scanning combined with liver-function studies. JAMA. 1969 Aug 4;209(5):676–679. [PubMed] [Google Scholar]
  19. YESNER R., CONN H. O. LIVER FUNCTION TESTS AND NEEDLE BIOPSY IN THE DIAGNOSIS OF METASTATIC CANCER OF THE LIVER. Ann Intern Med. 1963 Jul;59:62–73. doi: 10.7326/0003-4819-59-1-62. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES